Prognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma

作者: Yixin Zhang , Suqin Zhang , Xudong Wang , Jibin Liu , Liping Yang

DOI: 10.1136/JCLINPATH-2011-200547

关键词:

摘要: Background Forkhead Box P1 (FOXP1) has been described as both a tumour suppressor candidate and potential oncogene. The aim of this study is to identify new prognostic biomarkers therapeutic target structures for the diagnosis treatment hepatocellular carcinoma (HCC). Methods expression FOXP1 mRNA in HCC was characterised using real-time PCR 20 pairs fresh frozen tissues corresponding non-cancerous tissues. protein confirmed immunohistochemistry on tissue microarray chip. Finally, correlated with conventional clinicopathological features patient outcome. Results cells much higher than normal hepatic (Z=2.315, p=0.021 χ 2 =28.071, 95% CI 0.233 0.480, p test analysis showed that high related large diameter (χ =6.210, p=0.013), serum α-fetoprotein levels =6.920, p=0.031) later stage grouping node metastasis classification =6.714, p=0.035). Kaplan–Meier survival Cox regression (HR=2.182, 1.146 4.154, p=0.018) regional lymph (HR=2.326, 1.037 5.217, p=0.041) were independent prognosis factors. Conclusions From investigation authors elucidated first time correlation correlates an aggressive malignant phenotype may constitute novel factor HCC. These results also support role oncogene

参考文章(34)
E Ho, P Michielsen, Viral hepatitis B and hepatocellular carcinoma. Acta Gastro-enterologica Belgica. ,vol. 74, pp. 4- 8 ,(2011)
Lauri A. Aaltonen, Stanley R. Hamilton, Pathology and genetics of tumours of the digestive system IARC Press. ,(2000)
Sandrine Faivre, Mohamed Bouattour, Eric Raymond, Novel molecular therapies in hepatocellular carcinoma Liver International. ,vol. 31, pp. 151- 160 ,(2011) , 10.1111/J.1478-3231.2010.02395.X
Advanced Hepatocellular Carcinoma Blackwell Publishing Ltd.. pp. 77- 96 ,(2009) , 10.1002/9781444312775.CH6
Jianfei Huang, Huijun Zhu, Xudong Wang, Qi Tang, Hua Huang, Kerong Wu, Jin Zhu, Zhenqing Feng, Gongshen Shi, The patterns and expression of KDR in normal tissues of human internal organs. Journal of Molecular Histology. ,vol. 42, pp. 597- 603 ,(2011) , 10.1007/S10735-011-9355-1
Jharna Datta, Huban Kutay, Mohd W. Nasser, Gerard J. Nuovo, Bo Wang, Sarmila Majumder, Chang-Gong Liu, Stefano Volinia, Carlo M. Croce, Thomas D. Schmittgen, Kalpana Ghoshal, Samson T. Jacob, Methylation Mediated Silencing of MicroRNA-1 Gene and Its Role in Hepatocellular Carcinogenesis Cancer Research. ,vol. 68, pp. 5049- 5058 ,(2008) , 10.1158/0008-5472.CAN-07-6655
I Wlodarska, E Veyt, P De Paepe, P Vandenberghe, P Nooijen, I Theate, L Michaux, X Sagaert, P Marynen, A Hagemeijer, C De Wolf-Peeters, FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations Leukemia. ,vol. 19, pp. 1299- 1305 ,(2005) , 10.1038/SJ.LEU.2403813
Can Shi, Masashi Sakuma, Toshifumi Mooroka, Alison Liscoe, Huiyun Gao, Kevin J. Croce, Arjun Sharma, David Kaplan, David R. Greaves, Yunmei Wang, Daniel I. Simon, Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood. ,vol. 112, pp. 4699- 4711 ,(2008) , 10.1182/BLOOD-2008-01-137018
Alison H. Banham, Jane Boddy, Rosalind Launchbury, Cheng Han, Helen Turley, Peter R. Malone, Adrian L. Harris, Stephen B. Fox, Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. The Prostate. ,vol. 67, pp. 1091- 1098 ,(2007) , 10.1002/PROS.20583
Augusto Villanueva, Josep M. Llovet, Targeted Therapies for Hepatocellular Carcinoma Gastroenterology. ,vol. 140, pp. 1410- 1426 ,(2011) , 10.1053/J.GASTRO.2011.03.006